Indiana University School of Medicine, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana.
Indiana University School of Medicine, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana.
Clin Gastroenterol Hepatol. 2014 Dec;12(12):1973-80. doi: 10.1016/j.cgh.2013.09.052. Epub 2013 Oct 2.
In a recent article in The New York Times, "The $2.7 Trillion Medical Bill,"(1) colonoscopy was singled out for its cost. In their response, the leading gastroenterology professional societies highlighted colonoscopy's effectiveness and cost-effectiveness for the prevention of colorectal cancer (CRC). Affirming colonoscopy's central role in CRC prevention, both as a frontline test and as the final common pathway for other CRC screening modalities, requires strategies to measure and improve colonoscopy quality, particularly by controlling operator-dependent factors. Although colonoscopy is a powerful CRC screening test,(2-6) several recent studies have highlighted decreased protection, mainly against right-sided CRC,(5,7-16) an observation that has been linked to performance quality.
在《纽约时报》最近的一篇文章“2.7 万亿美元的医疗账单”（1）中，结肠镜检查因其费用而受到特别关注。在回应中，领先的胃肠病学专业协会强调了结肠镜检查在预防结直肠癌（CRC）方面的有效性和成本效益。为了肯定结肠镜检查在 CRC 预防中的核心作用，包括作为一线检测以及作为其他 CRC 筛查方式的最终共同途径，需要制定策略来衡量和提高结肠镜检查的质量，特别是通过控制操作人员相关的因素。尽管结肠镜检查是一种强大的 CRC 筛查测试（2-6），但最近的几项研究强调了保护作用的降低，主要是针对右侧 CRC（5、7-16），这种观察结果与性能质量有关。
